Lorraine Johnson invited to White House citizen science forum
LymeDisease.org CEO Lorraine Johnson has been selected to participate in a White House forum hosted by the…
LymeDisease.org CEO Lorraine Johnson has been selected to participate in a White House forum hosted by the…
by Kris Newby, Sept. 2, 2015 Meet Dan Salkeld, PhD, a disease ecologist and friend,…
In early October, the Infectious Diseases Society of America (IDSA)—you know, the Lyme denialists, the…
Press release from the University of California, Davis: July 2, 2015 The bacteria that cause…
Press release from Brigham and Women’s Hospital, June 4, 2015: From a single drop of…
Press release from Northeastern University, June 1, 2015: Northeastern University researchers have found that the…
Our latest issue looks at the troubling case of Vicki Logan, a cautionary tale by…
The IDSA’s Lyme review panel is supposed to consider the “patient perspective.”
The Infectious Diseases Society of America recently announced that it will finally be updating its Lyme disease guidelines. They have opened a 30-day window for the public to comment on their guideline development process. I’ve only had a few days to review their proposal, but I am deeply concerned by what I see.
New research suggests that a common allergy medication may be effective in starving and killing the bacteria that cause Lyme disease.
End of content
End of content